CN103181434A - 一种舒心保健茶及其制备方法 - Google Patents
一种舒心保健茶及其制备方法 Download PDFInfo
- Publication number
- CN103181434A CN103181434A CN2012101889381A CN201210188938A CN103181434A CN 103181434 A CN103181434 A CN 103181434A CN 2012101889381 A CN2012101889381 A CN 2012101889381A CN 201210188938 A CN201210188938 A CN 201210188938A CN 103181434 A CN103181434 A CN 103181434A
- Authority
- CN
- China
- Prior art keywords
- health protection
- comfortable health
- tea
- protection tea
- seed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 241001122767 Theaceae Species 0.000 title claims description 40
- 235000013616 tea Nutrition 0.000 claims abstract description 42
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 24
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 24
- 244000268590 Euryale ferox Species 0.000 claims abstract description 24
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 24
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 24
- 235000020339 pu-erh tea Nutrition 0.000 claims abstract description 20
- 235000019224 Camellia sinensis var Qingmao Nutrition 0.000 claims abstract description 17
- 230000036541 health Effects 0.000 claims description 40
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 27
- 240000007164 Salvia officinalis Species 0.000 claims description 25
- 235000005412 red sage Nutrition 0.000 claims description 24
- 241000208966 Polygala Species 0.000 claims description 22
- 240000002924 Platycladus orientalis Species 0.000 claims description 21
- 241000628997 Flos Species 0.000 claims description 20
- 230000009286 beneficial effect Effects 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 15
- 238000005520 cutting process Methods 0.000 claims description 14
- 230000008901 benefit Effects 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 5
- 230000003203 everyday effect Effects 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 230000035622 drinking Effects 0.000 claims description 3
- 240000008866 Ziziphus nummularia Species 0.000 claims 4
- 230000006870 function Effects 0.000 abstract description 10
- 210000002216 heart Anatomy 0.000 abstract description 10
- 230000007958 sleep Effects 0.000 abstract description 6
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 3
- 240000000559 Albizia odoratissima Species 0.000 abstract 1
- 235000011438 Albizia odoratissima Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 abstract 1
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract 1
- 241001080798 Polygala tenuifolia Species 0.000 abstract 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 235000008434 ginseng Nutrition 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 24
- 241001247821 Ziziphus Species 0.000 description 19
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 238000011161 development Methods 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 7
- 210000000952 spleen Anatomy 0.000 description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 206010022437 insomnia Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 208000007443 Neurasthenia Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108700012941 GNRH1 Proteins 0.000 description 2
- 239000000579 Gonadotropin-Releasing Hormone Substances 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000007969 cellular immunity Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical group N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 244000132619 red sage Species 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000025494 Aortic disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- -1 Phenylpropyl glucoside compound Chemical class 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000002992 thymic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种舒心保健茶,其包括如下重量分数的组分:普洱茶1~5份、人参0.2~1份、枣仁0.2~1.2份、丹参0.2~1份、麦冬0.1~0.9份、龙眼肉0.2~1份、茯神0.2~1份、芡实0.2~1.1份、龙齿0.2~1份、柏子仁0.1~0.6份、远志0.1~0.6份、合欢花0.1~0.6份和益志仁0.1~0.6份。以及,提供该舒心保健茶的制备方法。所述舒心保健茶通过合理配制,充分发挥了当中各组分的协效作用,具有养心安神、抗疲劳、增加记忆力、助睡眠、美容祛脂之功效,而且其制备工艺简单,成本低廉,易于生产。
Description
技术领域
本发明属于保健品技术领域,具体涉及一种舒心保健茶及其制备方法。
背景技术
饮茶文化在我国已有几千年的历史,通过饮茶达到舒缓紧张、预防保健的目的由来已久。《唐木章》说:“茗,苦茶,茶味甘苦,微寒无毒,一主瘘疮,利小便,去痰,解渴,令人少睡。”当前,处在社会信息化发展的高速阶段,环境污染、精神紧张、压力过大、营养过剩正一步步破坏着我们的健康。
中医所谓的“心”,除了指循环系统的心脏血管之外,还包含部分大脑中枢神经系统、内分泌系统以及精神情绪变化的功能,即“心主神明”是也。由于心血不足会出现心悸、失眠、健忘、面色无华等证。所以中医在养“心”的同时除了着重在心脏血管疾病的防治也兼顾到情绪的调适。慢性病中医门诊患者当中,因高血脂症及相关心血管疾病而前来求诊者不绝于途。
发明内容
本发明所要解决的技术问题在于克服现有技术之缺陷,提供一种舒心保健茶及其制备方法。
本发明提供一种舒心保健茶,其包括如下重量分数的组分:
普洱茶 1~5份;
人参 0.2~1份;
枣仁 0.2~1.2份;
丹参 0.2~1份;
麦冬 0.1~0.9份;
龙眼肉 0.2~1份;
茯神 0.2~1份;
芡实 0.2~1.1份;
龙齿 0.2~1份;
柏子仁 0.1~0.6份;
远志 0.1~0.6份;
合欢花 0.1~0.6份;
益志仁 0.1~0.6份。
以及,一种舒心保健茶的制备方法,其包括如下步骤:
选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;
分别将所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳,获得处理原料;
按照上述舒心保健茶的配方称取将所述处理原料、普洱茶、柏子仁和合欢花,并将其混合、杀菌,获得所述舒心保健茶。
本发明的舒心保健茶具有养心安神、抗疲劳、增加记忆力、助睡眠、美容祛脂的功效,原料无需深层次加工,浸泡使用即可,简单方便。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白,以下结合实施例,对本发明进行进一步详细说明。应当理解,此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。
本发明实施例的一种舒心保健茶,其包括如下重量分数的组分:
普洱茶 1~5份;
人参 0.2~1份;
枣仁 0.2~1.2份;
丹参 0.2~1份;
麦冬 0.1~0.9份;
龙眼肉 0.2~1份;
茯神 0.2~1份;
芡实 0.2~1.1份;
龙齿 0.2~1份;
柏子仁 0.1~0.6份;
远志 0.1~0.6份;
合欢花 0.1~0.6份;
益志仁 0.1~0.6份。
其中,所述普洱茶具有降脂、减肥、降压、抗动脉硬化、防癌、抗癌、养胃、护胃、健牙护齿、消炎、杀菌、治痢、抗衰老、凝神、美容、醒酒、利尿、养颜的作用。优选地,所述普洱茶为熟茶,用量为3~4份。
人参,人参的主要成分是人参皂甙以及人参多糖。人参皂甙和人参多糖是人参调节免疫功能的活性成分,对正常人和免疫功能低下的人均有提高免疫功能作用。人参多糖是人参中提纯的高分子酸性多糖,是一种免疫增强剂。经过动物实验和人体临床实验观察,证实其能显著增强人体免疫力,对恶性肿瘤有一定的疗效;临床实验可见其同样延长病人生存时间,提高机体细胞免疫功能,且减轻放疗的毒副作用,加快损伤组织的修复。应用人参多糖过程中未发现副作用,该味药安全、可靠。优选地,人参的用量为0.5~0.8份。
枣仁,别名酸枣核,山枣、酸枣仁。始载于《神农本草经》,列为上品,记载:补中益肝,坚筋骨,助阴气,皆酸枣仁之功也。其养肝,宁心,安神,敛汗。优选地,枣仁用量为0.5~0.9份。
丹参,又名赤参,紫丹参,红根等。为双子叶植物唇形科,干燥根及根茎。具有活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神的功效。丹参注射 液可使部分病人的胆固醇下降,在实验性动脉粥样硬化的大鼠,口服丹参煎剂未见有降低血脂的作用,对主动脉病变亦无保护作用。但对动脉粥样硬化家兔,可降低血和肝中的甘油三酯。复方丹参对高血脂家兔模型血清胆固醇、中性脂肪、β-脂蛋白亦有明显的降低作用.丹参及白花丹参能抑制家兔实验性冠状动脉大分支粥样斑块的形成.优选地,丹参用量为0.5~0.8份。
麦冬,性甘寒质润,有滋阴之功,能养阴生津,润肺清心,既善于清养肺胃之阴,又可清心经之热,是一味滋清兼备的补益良药。现代研究表明,麦冬含多种甾体皂苷、β-谷甾醇、豆甾醇等。其药理作用主要有(1)对心血管系统的作用:麦冬煎剂能显着提高实验动物耐缺氧能力,增加冠状动脉血流量,对心肌缺血有明显保护作用,并能抗心律失常及改善心肌收缩力;(2)抗血栓形成和改善微循环的作用;(3)抗菌作用:麦门冬粉,在平皿上对白色葡萄球菌、枯草杆菌、大肠杆菌及伤寒杆菌等有抗菌作用,50%全草煎剂对金黄色葡萄球菌、福氏痢疾杆菌和伤寒杆菌有抑制作用;(4)降糖作用:麦冬具有协调胰岛素功能,能降低血糖,促使胰岛细胞恢复正常。此外,麦冬有一定的镇静作用,还具有提高机体免疫功能的作用。优选地,麦冬用量为0.5~0.7份。
龙眼肉,龙眼配柏仁子,补心宁神;营养丰富,有壮阳益气、补益心脾、养血安神、润肤美容等多种功效,可治疗贫血、心悸、失眠、健忘、神经衰弱及病后、产后身体虚弱等症。优选地,龙眼肉的用量为0.5~0.9份。
茯神,性味甘、淡平,有有抗胃溃疡,保护肝细胞,增强心肌收缩力,增快心率,降低过度兴奋,利尿,促进细胞免疫与体液免疫,还有降血糖,抗肿瘤,抗病原微生物,促进造血等功能。优选地,茯神的用量为0.4~0.8份。
芡实,性平,味甘、涩,无毒;归脾、肾经。具有益肾固精、补脾止泻、祛湿止带的功能。治梦遗滑精、遗尿尿频、脾虚久泻、白浊、带下等症。实用性比较高,能够药食两用,最开始被记录于《神农本草经》中,随着后面的医学发展,发现芡实的功效与作用的确很强大,特别是对于心、肾、脾、胃具有很好的保健疗效。优选地,芡实的用量为0.5~0.9份。
龙齿,性味甘,涩,凉。宁心安神。用于神经衰弱,头晕目眩,心悸,失眠。本舒心保健茶中龙齿优选用量为0.4~0.7份。
柏子仁,柏子仁性平味甘。具养心安神、润肠通便的功效。治惊悸、失眠、遗精、盗汗、便秘等症。《日华子本草》载“治风,润皮肤。”《药品化义》载“柏子仁香气透心,体润滋血。”常食有健美作用。柏子仁用量优选为0.2~0.4份。
远志,性温,味苦、辛,具有安神益智、祛痰、消肿的功能,用于心肾不交引起的失眠多梦、健忘惊悸,神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。优选地,远志用量为0.2~0.4份。
合欢花,有宁神作用,主要是治郁结胸闷、失眠健忘、滋阴补阳、眼疾、神经衰弱等功效。合欢花易断、微香,优选地,取0.2~0.4份晒干的如团状合欢花。
益志仁,益智温脾,暖肾,固气,涩精。治冷气腹痛,中寒吐泻,多唾,遗精,小便余沥,夜多小便。益智能补肾壮阳,固精缩尿,温脾止泄,悦色延年,提高记忆力。而且是"久服轻身",的确是一味补肾防衰良药。据现代药理研究证实,益智仁含有多种化合物、微量生物及结晶性中性物质等营养成分,其水煎剂和乙醇浸出物能够增强阳虚动物的脾脏和增加胸腺重量,说明它对特异性细胞免疫功能也有促进作用,并能改善阳虚动物的营养、体重和耐受力等,对阳虚怕冷的病人有明显的强壮和治疗作用。益智中所含的苯丙基糖甙类化合物能明显提高男性的性功能和记忆力,并具有预防性行为降低的作用。最新研究还发现,益智还能增强女性下丘脑――垂体――卵巢的促黄体功能,提高垂体对黄体生成素释放激素的反应和卵巢对黄体酮生成素的反应,从而促进女性性功能。优选地,益志仁用量为0.2~0.4份。
上述舒心保健茶成年人每次用量为8~15g,每天1~2次,可以达到养心安神、抗疲劳、增加记忆力、助睡眠的功效。
由于中药的各原料之间存在相生、相须、相畏或者相杀等多种相互作用的 关系,因此根据上述各成分的功效以及特点,限定其组成,使其具有宁神安神、美容祛脂的作用。
本发明实施例还提供上述舒心保健茶的制备方法,其包括如下步骤:
S01:选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;
S02:分别将所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳,获得处理原料;
S03:按照上述舒心保健茶的配方称取将所述处理原料、普洱茶、柏子仁和合欢花,并将其混合、杀菌,获得所述舒心保健茶。
步骤S01中,所述原料应当选择较好物种,并进行筛选以除去杂质。
步骤S02中,对所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状均是为了在后续使用中能够更好的发挥其作用。颗粒以尽可能的小,但不会悬浮于浸泡液中影响口感为基准。所述龙眼去籽,所述益志仁去壳也是为了更好的发挥药效。
步骤S03中,普洱茶、柏子仁和合欢花无需进行切片或者粉碎等加工,直接使用即可。
进一步,为了使用方便,可将8~15g所述舒心保健茶进行包装,以便后续饮用。
本发明实施例的舒心保健茶的制备方法,简单,成本低廉。
以下通过具体配方和制备工艺的实施例来说明上述舒心保健茶及其制备方法。
实施例1:
选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;分别将所述人参、枣仁、丹参、麦冬、茯神、 芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳;将普洱茶4份、人参0.7份、枣仁0.7份、丹参0.8份、麦冬0.7份、龙眼0.7份、茯神0.7份、芡实0.7份、龙齿0.7份、柏子仁0.4份、远志0.3份、合欢花0.2份和益志仁0.3份混合,杀菌,获得舒心保健茶。
实施例2:
选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;分别将所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳;将普洱茶1份、人参1份、枣仁0.2份、丹参0.2份、麦冬1份、龙眼1份、茯神0.4份、芡实0.2份、龙齿0.2份、柏子仁0.6份、远志0.1份、合欢花0.6份和益志仁0.1份混合,杀菌,获得舒心保健茶。
实施例3:
选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;分别将所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳;将普洱茶5份、人参0.2份、枣仁1份、丹参1份、麦冬0.1份、龙眼0.2份、茯神1份、芡实1.1份、龙齿1份、柏子仁0.1份、远志0.1份、合欢花0.1份和益志仁0.6份混合,杀菌,获得舒心保健茶。
实施例4:
选择10位睡眠不好、多梦的成年人和老年人试用,每人每天饮用实施例1中所制备的舒心保健茶10g,连续饮用一个月,有9人睡眠质量提高。
实施例5:
选择20位工作压力大,亚健康的成年人试用,每人每天饮用实施例3 中所制备的舒心保健茶10g,连续饮用半年,有16人反映身体状况有明显改善,精神与往常相比较好。
以上所述仅为本发明的较佳实施例而已,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (6)
1.一种舒心保健茶,其特征在于,包括如下重量分数的组分:
普洱茶 1~5份;
人参 0.2~1份;
枣仁 0.2~1.2份;
丹参 0.2~1份;
麦冬 0.1~0.9份;
龙眼肉 0.2~1份;
茯神 0.2~1份;
芡实 0.2~1.1份;
龙齿 0.2~1份;
柏子仁 0.1~0.6份;
远志 0.1~0.6份;
合欢花 0.1~0.6份;
益志仁 0.1~0.6份。
2.如权利要求1所述的舒心保健茶,其特征在于,所述舒心保健茶包括如下重量分数的组分:
普洱茶 3~4份;
人参 0.5~0.8份;
枣仁 0.5~0.9份;
丹参 0.5~0.8份;
麦冬 0.5~0.7份;
龙眼肉 0.5~0.9份;
茯神 0.4~0.8份;
芡实 0.4~0.8份;
龙齿 0.4~0.7份;
柏子仁 0.2~0.4份;
远志 0.2~0.4份;
合欢花 0.2~0.4份;
益志仁 0.2~0.4份。
3.如权利要求1所述的舒心保健茶,其特征在于,所述舒心保健茶成年人每人每次饮用量为8~15g。
4.如权利要求1所述的舒心保健茶,其特征在于,所述舒心保健茶成年人每人每天饮用次数为1~2次。
5.一种舒心保健茶的制备方法,其特征在于,包括如下步骤:
选取原料普洱茶、人参、枣仁、丹参、麦冬、龙眼、茯神、芡实、龙齿、柏子仁、远志、合欢花和益志仁;
分别将所述人参、枣仁、丹参、麦冬、茯神、芡实、龙齿、远志切割或裁剪或粉碎成颗粒状,所述龙眼去籽,所述益志仁去壳,获得处理原料;
按照权利要求1~4所述的舒心保健茶的配方称取将所述处理原料、普洱茶、柏子仁和合欢花,并将其混合、杀菌,获得所述舒心保健茶。
6.如权利要求5所述的舒心保健茶的制备方法,其特征在于,称取所述舒心保健茶8~15g进行包装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210188938.1A CN103181434B (zh) | 2012-06-06 | 2012-06-06 | 一种舒心保健茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210188938.1A CN103181434B (zh) | 2012-06-06 | 2012-06-06 | 一种舒心保健茶及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103181434A true CN103181434A (zh) | 2013-07-03 |
CN103181434B CN103181434B (zh) | 2014-09-10 |
Family
ID=48673094
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210188938.1A Expired - Fee Related CN103181434B (zh) | 2012-06-06 | 2012-06-06 | 一种舒心保健茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103181434B (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623095A (zh) * | 2013-11-26 | 2014-03-12 | 任新年 | 一种治疗焦虑症的中药及其制备方法 |
CN104171120A (zh) * | 2014-07-29 | 2014-12-03 | 安徽明珍堂养生品有限公司 | 一种合欢红枣安神茶及其制备方法 |
CN105124026A (zh) * | 2014-05-27 | 2015-12-09 | 李建峰 | 一种安神的普洱茶组合物 |
CN105145990A (zh) * | 2015-09-23 | 2015-12-16 | 安徽阳光药业有限公司 | 一种益智安神保健凉茶及其制备方法 |
CN105795033A (zh) * | 2016-04-28 | 2016-07-27 | 云南归北农业发展有限公司 | 一种美容养颜保健普洱茶及其制备方法 |
CN111213753A (zh) * | 2020-03-16 | 2020-06-02 | 宁洱普义雾露山仙女茶厂 | 一种具有助眠功能的茶饮 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435102A (zh) * | 2002-01-26 | 2003-08-13 | 王乐观 | 人参普洱茶 |
CN1528402A (zh) * | 2003-10-13 | 2004-09-15 | 张华贵 | 一种滋补安眠液 |
CN1718070A (zh) * | 2005-07-25 | 2006-01-11 | 王浩贵 | 一种芡实保健茶 |
CN101164587A (zh) * | 2007-09-29 | 2008-04-23 | 李生 | 治疗心悸不宁、胸闷气短的中药 |
CN101244195A (zh) * | 2008-02-17 | 2008-08-20 | 李毅 | 一种治疗失眠的药物 |
CN101327296A (zh) * | 2008-07-23 | 2008-12-24 | 武汉理工大学 | 用于治疗和改善失眠症状的复方中药制剂及其制备方法 |
CN102048946A (zh) * | 2009-10-28 | 2011-05-11 | 刘庆华 | 一种治疗失眠的中药方 |
CN102370924A (zh) * | 2011-09-28 | 2012-03-14 | 邓华伦 | 治疗心痹症的中草药 |
CN102451366A (zh) * | 2010-10-25 | 2012-05-16 | 韩丽华 | 一种抗心律失常中药胶囊 |
-
2012
- 2012-06-06 CN CN201210188938.1A patent/CN103181434B/zh not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1435102A (zh) * | 2002-01-26 | 2003-08-13 | 王乐观 | 人参普洱茶 |
CN1528402A (zh) * | 2003-10-13 | 2004-09-15 | 张华贵 | 一种滋补安眠液 |
CN1718070A (zh) * | 2005-07-25 | 2006-01-11 | 王浩贵 | 一种芡实保健茶 |
CN101164587A (zh) * | 2007-09-29 | 2008-04-23 | 李生 | 治疗心悸不宁、胸闷气短的中药 |
CN101244195A (zh) * | 2008-02-17 | 2008-08-20 | 李毅 | 一种治疗失眠的药物 |
CN101327296A (zh) * | 2008-07-23 | 2008-12-24 | 武汉理工大学 | 用于治疗和改善失眠症状的复方中药制剂及其制备方法 |
CN102048946A (zh) * | 2009-10-28 | 2011-05-11 | 刘庆华 | 一种治疗失眠的中药方 |
CN102451366A (zh) * | 2010-10-25 | 2012-05-16 | 韩丽华 | 一种抗心律失常中药胶囊 |
CN102370924A (zh) * | 2011-09-28 | 2012-03-14 | 邓华伦 | 治疗心痹症的中草药 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103623095A (zh) * | 2013-11-26 | 2014-03-12 | 任新年 | 一种治疗焦虑症的中药及其制备方法 |
CN105124026A (zh) * | 2014-05-27 | 2015-12-09 | 李建峰 | 一种安神的普洱茶组合物 |
CN104171120A (zh) * | 2014-07-29 | 2014-12-03 | 安徽明珍堂养生品有限公司 | 一种合欢红枣安神茶及其制备方法 |
CN105145990A (zh) * | 2015-09-23 | 2015-12-16 | 安徽阳光药业有限公司 | 一种益智安神保健凉茶及其制备方法 |
CN105795033A (zh) * | 2016-04-28 | 2016-07-27 | 云南归北农业发展有限公司 | 一种美容养颜保健普洱茶及其制备方法 |
CN111213753A (zh) * | 2020-03-16 | 2020-06-02 | 宁洱普义雾露山仙女茶厂 | 一种具有助眠功能的茶饮 |
Also Published As
Publication number | Publication date |
---|---|
CN103181434B (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102986887B (zh) | 一种养生风味奶昔及其制备方法 | |
CN102784295B (zh) | 一种改善女性更年期综合症的保健制剂配方及其制备方法 | |
CN103181434B (zh) | 一种舒心保健茶及其制备方法 | |
CN103689563A (zh) | 一种有助于改善睡眠的养生保健食品配方及其制备方法 | |
CN102824472A (zh) | 一种用于女性补气养血的药酒 | |
CN103054054A (zh) | 一种美容猪皮冻及其制备方法 | |
CN103740565B (zh) | 抗疲劳调心情的美容养生酒及其制备方法 | |
CN106509219A (zh) | 一种滋阴养生茶及其制备方法 | |
CN101982138B (zh) | 怡神解郁药枕 | |
CN103349121B (zh) | 降三高保健茶及其制备方法 | |
CN105434857A (zh) | 一种疏肝化瘀祛斑的佛手保健口服液及其制备方法 | |
CN103182051B (zh) | 一种护胃保健茶及其制备方法 | |
CN102860390B (zh) | 一种桑叶减肥茶及其制备方法 | |
CN103053767B (zh) | 一种苁蓉保健营养茶制备方法 | |
CN103181432B (zh) | 一种补肾保健茶及其制备方法 | |
CN105685317A (zh) | 富含硒火麻茶及其制备方法 | |
CN104274754A (zh) | 一种治疗小儿遗尿的中药组合物及其制备方法 | |
CN109224021A (zh) | 治疗糖尿病、降血压、降血脂的保健养生茶及制备方法 | |
CN108041397A (zh) | 一种提升睡眠质量的固体饮料 | |
CN106728385A (zh) | 一种通经络补气血的中药组合物及其制备方法和用途 | |
CN106036906A (zh) | 一种养血安神富硒葛根龟苓膏及其制备方法 | |
CN104840686A (zh) | 一种降压保健茶 | |
CN104274755A (zh) | 一种治疗小儿遗尿的中药制剂及其制备方法 | |
CN104984150A (zh) | 具有降血压功效养生粥的制备工艺 | |
CN103637272B (zh) | 一种适合秋冬进补的莲子粉 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140910 Termination date: 20190606 |
|
CF01 | Termination of patent right due to non-payment of annual fee |